Structure

Physi-Chem Properties

Molecular Weight:  368.13
Volume:  381.036
LogP:  2.742
LogD:  2.82
LogS:  -3.921
# Rotatable Bonds:  8
TPSA:  93.06
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  2
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.548
Synthetic Accessibility Score:  2.426
Fsp3:  0.143
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  2
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.834
MDCK Permeability:  1.632656858419068e-05
Pgp-inhibitor:  0.284
Pgp-substrate:  0.014
Human Intestinal Absorption (HIA):  0.06
20% Bioavailability (F20%):  0.011
30% Bioavailability (F30%):  0.171

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.103
Plasma Protein Binding (PPB):  99.79946899414062%
Volume Distribution (VD):  0.369
Pgp-substrate:  1.0492939949035645%

ADMET: Metabolism

CYP1A2-inhibitor:  0.593
CYP1A2-substrate:  0.758
CYP2C19-inhibitor:  0.287
CYP2C19-substrate:  0.12
CYP2C9-inhibitor:  0.661
CYP2C9-substrate:  0.906
CYP2D6-inhibitor:  0.037
CYP2D6-substrate:  0.895
CYP3A4-inhibitor:  0.674
CYP3A4-substrate:  0.517

ADMET: Excretion

Clearance (CL):  13.839
Half-life (T1/2):  0.948

ADMET: Toxicity

hERG Blockers:  0.214
Human Hepatotoxicity (H-HT):  0.475
Drug-inuced Liver Injury (DILI):  0.895
AMES Toxicity:  0.234
Rat Oral Acute Toxicity:  0.896
Maximum Recommended Daily Dose:  0.776
Skin Sensitization:  0.958
Carcinogencity:  0.706
Eye Corrosion:  0.007
Eye Irritation:  0.792
Respiratory Toxicity:  0.951

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC18984

Natural Product ID:  NPC18984
Common Name*:   1,7-Bis(4-Hydroxy-3-Methoxyphenyl)Hepta-1,6-Diene-3,5-Dione
IUPAC Name:   1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
Synonyms:  
Standard InCHIKey:  VFLDPWHFBUODDF-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-12,24-25H,13H2,1-2H3
SMILES:  COc1cc(C=CC(=O)CC(=O)C=Cc2ccc(c(c2)OC)O)ccc1O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3187799
PubChem CID:   2889
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002650] Diarylheptanoids
        • [CHEMONTID:0002651] Linear diarylheptanoids
          • [CHEMONTID:0000356] Curcuminoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9241 Adiantum capillus-veneris Species Pteridaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO7308 Fraxinus quadrangulata Species Oleaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO3251 Jacobaea maritima Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO7308 Fraxinus quadrangulata Species Oleaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO9241 Adiantum capillus-veneris Species Pteridaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO9241 Adiantum capillus-veneris Species Pteridaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO25160 Goniothalamus borneensis Species Annonaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO3532 Tridentata marginata n.a. n.a. n.a. n.a. n.a. n.a. Database[UNPD]
NPO9241 Adiantum capillus-veneris Species Pteridaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO7308 Fraxinus quadrangulata Species Oleaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO3251 Jacobaea maritima Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Potency n.a. 5304.5 nM PMID[498306]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Potency n.a. 8407.1 nM PMID[498306]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC18984 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC160900
1.0 High Similarity NPC106659
1.0 High Similarity NPC229084
0.9741 High Similarity NPC14007
0.9741 High Similarity NPC109083
0.9741 High Similarity NPC224814
0.9741 High Similarity NPC269843
0.9741 High Similarity NPC189844
0.9741 High Similarity NPC60962
0.9583 High Similarity NPC276014
0.9576 High Similarity NPC286573
0.9508 High Similarity NPC304622
0.9504 High Similarity NPC276466
0.9504 High Similarity NPC123722
0.9504 High Similarity NPC123228
0.9504 High Similarity NPC5018
0.9504 High Similarity NPC151167
0.9421 High Similarity NPC84076
0.9421 High Similarity NPC179777
0.9421 High Similarity NPC90128
0.9421 High Similarity NPC303680
0.9407 High Similarity NPC158949
0.9397 High Similarity NPC280001
0.9397 High Similarity NPC185738
0.9262 High Similarity NPC92207
0.9262 High Similarity NPC127937
0.9256 High Similarity NPC246704
0.918 High Similarity NPC257589
0.918 High Similarity NPC289459
0.918 High Similarity NPC53305
0.9174 High Similarity NPC164778
0.9174 High Similarity NPC4181
0.9174 High Similarity NPC257976
0.9174 High Similarity NPC242372
0.912 High Similarity NPC66905
0.9113 High Similarity NPC110313
0.9106 High Similarity NPC120225
0.9106 High Similarity NPC213552
0.9098 High Similarity NPC273686
0.9098 High Similarity NPC312404
0.9091 High Similarity NPC114298
0.9016 High Similarity NPC163083
0.8992 High Similarity NPC164706
0.8992 High Similarity NPC137537
0.8992 High Similarity NPC272471
0.8992 High Similarity NPC107588
0.8992 High Similarity NPC470626
0.8992 High Similarity NPC70744
0.8983 High Similarity NPC268317
0.8968 High Similarity NPC172673
0.8966 High Similarity NPC51698
0.896 High Similarity NPC478215
0.896 High Similarity NPC226661
0.8926 High Similarity NPC204466
0.8908 High Similarity NPC293619
0.8908 High Similarity NPC39793
0.8889 High Similarity NPC83062
0.8871 High Similarity NPC87113
0.8852 High Similarity NPC201777
0.8852 High Similarity NPC70752
0.8843 High Similarity NPC95614
0.8843 High Similarity NPC227217
0.8843 High Similarity NPC56214
0.8843 High Similarity NPC232316
0.8843 High Similarity NPC117780
0.8843 High Similarity NPC165133
0.8843 High Similarity NPC202474
0.8843 High Similarity NPC242885
0.8843 High Similarity NPC2058
0.8828 High Similarity NPC239302
0.8819 High Similarity NPC137427
0.8819 High Similarity NPC244246
0.8819 High Similarity NPC215941
0.8819 High Similarity NPC311419
0.8819 High Similarity NPC65935
0.8819 High Similarity NPC123196
0.8819 High Similarity NPC319282
0.8819 High Similarity NPC275724
0.879 High Similarity NPC60517
0.879 High Similarity NPC146886
0.879 High Similarity NPC20443
0.8788 High Similarity NPC474784
0.877 High Similarity NPC207613
0.877 High Similarity NPC471877
0.876 High Similarity NPC327410
0.876 High Similarity NPC310338
0.876 High Similarity NPC281298
0.876 High Similarity NPC299406
0.872 High Similarity NPC3221
0.8712 High Similarity NPC284409
0.871 High Similarity NPC238810
0.8707 High Similarity NPC246358
0.8707 High Similarity NPC36108
0.8707 High Similarity NPC7097
0.8707 High Similarity NPC233731
0.8702 High Similarity NPC90431
0.8699 High Similarity NPC113865
0.8699 High Similarity NPC184651
0.8699 High Similarity NPC54872
0.8699 High Similarity NPC343720
0.8699 High Similarity NPC160380
0.8699 High Similarity NPC262156
0.8699 High Similarity NPC38996
0.8699 High Similarity NPC312675
0.8699 High Similarity NPC473853
0.8699 High Similarity NPC470212
0.8699 High Similarity NPC324571
0.8678 High Similarity NPC277460
0.8657 High Similarity NPC472410
0.8655 High Similarity NPC294941
0.8629 High Similarity NPC262253
0.8629 High Similarity NPC71579
0.8629 High Similarity NPC473411
0.8629 High Similarity NPC85488
0.8626 High Similarity NPC477301
0.8595 High Similarity NPC86947
0.8594 High Similarity NPC241354
0.8583 High Similarity NPC20404
0.8583 High Similarity NPC16651
0.8583 High Similarity NPC293641
0.8583 High Similarity NPC32163
0.8583 High Similarity NPC20287
0.8583 High Similarity NPC12022
0.8571 High Similarity NPC280767
0.8571 High Similarity NPC67951
0.8571 High Similarity NPC197832
0.856 High Similarity NPC317769
0.856 High Similarity NPC31344
0.856 High Similarity NPC306100
0.856 High Similarity NPC280704
0.856 High Similarity NPC471693
0.8559 High Similarity NPC78918
0.8559 High Similarity NPC173746
0.8559 High Similarity NPC8547
0.8559 High Similarity NPC297657
0.8559 High Similarity NPC156840
0.8559 High Similarity NPC139617
0.8559 High Similarity NPC257124
0.855 High Similarity NPC119060
0.855 High Similarity NPC111635
0.855 High Similarity NPC135127
0.855 High Similarity NPC237594
0.855 High Similarity NPC471110
0.855 High Similarity NPC249791
0.855 High Similarity NPC476387
0.8548 High Similarity NPC194416
0.8548 High Similarity NPC177291
0.8537 High Similarity NPC474565
0.8537 High Similarity NPC247364
0.8537 High Similarity NPC232084
0.8537 High Similarity NPC61516
0.8537 High Similarity NPC10932
0.8525 High Similarity NPC212743
0.8525 High Similarity NPC275519
0.8516 High Similarity NPC278308
0.8512 High Similarity NPC19290
0.8512 High Similarity NPC61062
0.8512 High Similarity NPC299252
0.8512 High Similarity NPC277394
0.8507 High Similarity NPC288452
0.8507 High Similarity NPC289690
0.8504 High Similarity NPC118584
0.8492 Intermediate Similarity NPC74478
0.8485 Intermediate Similarity NPC152209
0.8485 Intermediate Similarity NPC204592
0.848 Intermediate Similarity NPC256167
0.8473 Intermediate Similarity NPC36490
0.8473 Intermediate Similarity NPC475468
0.8468 Intermediate Similarity NPC470849
0.8468 Intermediate Similarity NPC470848
0.8468 Intermediate Similarity NPC166759
0.8456 Intermediate Similarity NPC169214
0.8456 Intermediate Similarity NPC229218
0.8456 Intermediate Similarity NPC192597
0.8456 Intermediate Similarity NPC141817
0.8456 Intermediate Similarity NPC176030
0.8455 Intermediate Similarity NPC24474
0.8455 Intermediate Similarity NPC141791
0.8455 Intermediate Similarity NPC311595
0.8455 Intermediate Similarity NPC37858
0.8455 Intermediate Similarity NPC263386
0.8444 Intermediate Similarity NPC78987
0.8444 Intermediate Similarity NPC82336
0.8443 Intermediate Similarity NPC164386
0.8438 Intermediate Similarity NPC117237
0.8438 Intermediate Similarity NPC203719
0.8425 Intermediate Similarity NPC271985
0.8425 Intermediate Similarity NPC116907
0.8425 Intermediate Similarity NPC228771
0.8425 Intermediate Similarity NPC58279
0.8425 Intermediate Similarity NPC193544
0.8425 Intermediate Similarity NPC221077
0.8425 Intermediate Similarity NPC298757
0.8425 Intermediate Similarity NPC265483
0.8425 Intermediate Similarity NPC17943
0.8425 Intermediate Similarity NPC472093
0.8425 Intermediate Similarity NPC266705
0.8425 Intermediate Similarity NPC57490
0.8425 Intermediate Similarity NPC148627
0.8425 Intermediate Similarity NPC194519

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC18984 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
1.0 High Similarity NPD4379 Clinical (unspecified phase)
0.9397 High Similarity NPD5536 Phase 2
0.8559 High Similarity NPD228 Approved
0.8438 Intermediate Similarity NPD9494 Approved
0.8264 Intermediate Similarity NPD5283 Phase 1
0.8168 Intermediate Similarity NPD3027 Phase 3
0.7934 Intermediate Similarity NPD3022 Approved
0.7934 Intermediate Similarity NPD3021 Approved
0.7817 Intermediate Similarity NPD4357 Discontinued
0.7769 Intermediate Similarity NPD1358 Approved
0.7734 Intermediate Similarity NPD1357 Approved
0.7718 Intermediate Similarity NPD3882 Suspended
0.771 Intermediate Similarity NPD2983 Phase 2
0.771 Intermediate Similarity NPD2982 Phase 2
0.7703 Intermediate Similarity NPD2801 Approved
0.7692 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7635 Intermediate Similarity NPD1934 Approved
0.7634 Intermediate Similarity NPD2981 Phase 2
0.763 Intermediate Similarity NPD7095 Approved
0.7591 Intermediate Similarity NPD4060 Phase 1
0.7591 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7591 Intermediate Similarity NPD3620 Phase 2
0.7586 Intermediate Similarity NPD9296 Approved
0.7574 Intermediate Similarity NPD3145 Approved
0.7574 Intermediate Similarity NPD3144 Approved
0.7571 Intermediate Similarity NPD2935 Discontinued
0.7556 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7541 Intermediate Similarity NPD3134 Approved
0.7518 Intermediate Similarity NPD2674 Phase 3
0.7518 Intermediate Similarity NPD7266 Discontinued
0.75 Intermediate Similarity NPD3972 Approved
0.7483 Intermediate Similarity NPD8166 Discontinued
0.7481 Intermediate Similarity NPD3018 Phase 2
0.7481 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7481 Intermediate Similarity NPD3847 Discontinued
0.7467 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7464 Intermediate Similarity NPD1613 Approved
0.7464 Intermediate Similarity NPD1558 Phase 1
0.7464 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7462 Intermediate Similarity NPD1651 Approved
0.7448 Intermediate Similarity NPD1511 Approved
0.7444 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7431 Intermediate Similarity NPD6190 Approved
0.7419 Intermediate Similarity NPD2684 Approved
0.741 Intermediate Similarity NPD447 Suspended
0.7405 Intermediate Similarity NPD4626 Approved
0.7402 Intermediate Similarity NPD1241 Discontinued
0.7388 Intermediate Similarity NPD1876 Approved
0.7361 Intermediate Similarity NPD4628 Phase 3
0.7361 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7361 Intermediate Similarity NPD4110 Phase 3
0.7347 Intermediate Similarity NPD1512 Approved
0.7323 Intermediate Similarity NPD7843 Approved
0.7319 Intermediate Similarity NPD6798 Discontinued
0.7315 Intermediate Similarity NPD3455 Phase 2
0.7315 Intermediate Similarity NPD824 Approved
0.7297 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD3060 Approved
0.7288 Intermediate Similarity NPD2934 Approved
0.7288 Intermediate Similarity NPD2933 Approved
0.7287 Intermediate Similarity NPD7157 Approved
0.7286 Intermediate Similarity NPD230 Phase 1
0.7286 Intermediate Similarity NPD6355 Discontinued
0.7267 Intermediate Similarity NPD7028 Phase 2
0.7266 Intermediate Similarity NPD6233 Phase 2
0.7266 Intermediate Similarity NPD4062 Phase 3
0.7261 Intermediate Similarity NPD6166 Phase 2
0.7261 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7259 Intermediate Similarity NPD1283 Approved
0.7259 Intermediate Similarity NPD2922 Phase 1
0.7258 Intermediate Similarity NPD968 Approved
0.7255 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD1653 Approved
0.7227 Intermediate Similarity NPD2860 Approved
0.7227 Intermediate Similarity NPD2859 Approved
0.7218 Intermediate Similarity NPD3496 Discontinued
0.7214 Intermediate Similarity NPD943 Approved
0.7214 Intermediate Similarity NPD1240 Approved
0.72 Intermediate Similarity NPD3866 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD5585 Approved
0.7194 Intermediate Similarity NPD5111 Phase 2
0.7194 Intermediate Similarity NPD5110 Phase 2
0.7194 Intermediate Similarity NPD5109 Approved
0.719 Intermediate Similarity NPD3020 Approved
0.719 Intermediate Similarity NPD3817 Phase 2
0.7188 Intermediate Similarity NPD5535 Approved
0.7174 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD3818 Discontinued
0.7164 Intermediate Similarity NPD3705 Approved
0.7164 Intermediate Similarity NPD1535 Discovery
0.7163 Intermediate Similarity NPD1933 Approved
0.7154 Intermediate Similarity NPD6671 Approved
0.7153 Intermediate Similarity NPD2344 Approved
0.7153 Intermediate Similarity NPD6584 Phase 3
0.7153 Intermediate Similarity NPD2798 Approved
0.7133 Intermediate Similarity NPD2799 Discontinued
0.7133 Intermediate Similarity NPD1510 Phase 2
0.7125 Intermediate Similarity NPD7054 Approved
0.7121 Intermediate Similarity NPD1894 Discontinued
0.7113 Intermediate Similarity NPD1607 Approved
0.7113 Intermediate Similarity NPD2492 Phase 1
0.7111 Intermediate Similarity NPD1481 Phase 2
0.7103 Intermediate Similarity NPD2424 Discontinued
0.7087 Intermediate Similarity NPD5451 Approved
0.7081 Intermediate Similarity NPD7074 Phase 3
0.7081 Intermediate Similarity NPD7472 Approved
0.708 Intermediate Similarity NPD2797 Approved
0.708 Intermediate Similarity NPD1203 Approved
0.7073 Intermediate Similarity NPD291 Approved
0.7071 Intermediate Similarity NPD3268 Approved
0.7071 Intermediate Similarity NPD5718 Phase 2
0.707 Intermediate Similarity NPD2821 Approved
0.7068 Intermediate Similarity NPD5691 Approved
0.7063 Intermediate Similarity NPD290 Approved
0.7055 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD4162 Approved
0.7051 Intermediate Similarity NPD6234 Discontinued
0.7042 Intermediate Similarity NPD4340 Discontinued
0.7039 Intermediate Similarity NPD4380 Phase 2
0.7037 Intermediate Similarity NPD1281 Approved
0.7025 Intermediate Similarity NPD6232 Discontinued
0.7015 Intermediate Similarity NPD5846 Approved
0.7015 Intermediate Similarity NPD1778 Approved
0.7015 Intermediate Similarity NPD6516 Phase 2
0.7007 Intermediate Similarity NPD3225 Approved
0.7 Intermediate Similarity NPD7473 Discontinued
0.6994 Remote Similarity NPD7685 Pre-registration
0.6993 Remote Similarity NPD6873 Phase 2
0.6993 Remote Similarity NPD6653 Approved
0.6993 Remote Similarity NPD6386 Approved
0.6993 Remote Similarity NPD6385 Approved
0.6992 Remote Similarity NPD9545 Approved
0.6992 Remote Similarity NPD1242 Phase 1
0.6985 Remote Similarity NPD1608 Approved
0.698 Remote Similarity NPD6799 Approved
0.6978 Remote Similarity NPD2861 Phase 2
0.6974 Remote Similarity NPD7458 Discontinued
0.6966 Remote Similarity NPD6032 Approved
0.6959 Remote Similarity NPD2309 Approved
0.6959 Remote Similarity NPD2354 Approved
0.6959 Remote Similarity NPD5241 Discontinued
0.695 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6948 Remote Similarity NPD37 Approved
0.6944 Remote Similarity NPD6895 Approved
0.6944 Remote Similarity NPD6896 Approved
0.6939 Remote Similarity NPD4236 Phase 3
0.6939 Remote Similarity NPD4237 Approved
0.6934 Remote Similarity NPD4359 Approved
0.6934 Remote Similarity NPD6582 Phase 2
0.6934 Remote Similarity NPD6583 Phase 3
0.6933 Remote Similarity NPD4123 Phase 3
0.6933 Remote Similarity NPD6797 Phase 2
0.6933 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6929 Remote Similarity NPD4908 Phase 1
0.6928 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6918 Remote Similarity NPD3540 Phase 1
0.6912 Remote Similarity NPD422 Phase 1
0.6909 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6906 Remote Similarity NPD5647 Approved
0.6903 Remote Similarity NPD1465 Phase 2
0.6903 Remote Similarity NPD2978 Approved
0.6903 Remote Similarity NPD2977 Approved
0.6901 Remote Similarity NPD1726 Clinical (unspecified phase)
0.6892 Remote Similarity NPD6331 Phase 2
0.6892 Remote Similarity NPD3750 Approved
0.6892 Remote Similarity NPD7003 Approved
0.689 Remote Similarity NPD7251 Discontinued
0.6889 Remote Similarity NPD2668 Approved
0.6889 Remote Similarity NPD2667 Approved
0.6889 Remote Similarity NPD3019 Approved
0.6889 Remote Similarity NPD2932 Approved
0.6889 Remote Similarity NPD2423 Clinical (unspecified phase)
0.6879 Remote Similarity NPD7075 Discontinued
0.6875 Remote Similarity NPD2653 Approved
0.6871 Remote Similarity NPD1549 Phase 2
0.6871 Remote Similarity NPD4534 Discontinued
0.6867 Remote Similarity NPD5297 Approved
0.6866 Remote Similarity NPD1548 Phase 1
0.6863 Remote Similarity NPD3111 Phase 1
0.6861 Remote Similarity NPD2232 Approved
0.6861 Remote Similarity NPD9269 Phase 2
0.6861 Remote Similarity NPD2230 Approved
0.6861 Remote Similarity NPD9717 Approved
0.6861 Remote Similarity NPD2233 Approved
0.6859 Remote Similarity NPD5977 Approved
0.6859 Remote Similarity NPD5978 Approved
0.6855 Remote Similarity NPD8127 Discontinued
0.6853 Remote Similarity NPD2979 Phase 3
0.6853 Remote Similarity NPD825 Approved
0.6853 Remote Similarity NPD826 Approved
0.6849 Remote Similarity NPD2438 Suspended
0.6849 Remote Similarity NPD3539 Phase 1
0.6848 Remote Similarity NPD7808 Phase 3
0.6848 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6846 Remote Similarity NPD2219 Phase 1
0.6842 Remote Similarity NPD6662 Clinical (unspecified phase)
0.6842 Remote Similarity NPD9493 Approved
0.6835 Remote Similarity NPD3053 Approved
0.6835 Remote Similarity NPD3055 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data